TY - JOUR
T1 - Antegrade Versus Retrograde Isolated Lung Perfusion
T2 - Doxorubicin Uptake and Distribution in a Sarcoma Model
AU - Krueger, Thorsten
AU - Kuemmerle, Andrea
AU - Andrejevic-Blant, Snezana
AU - Yan, Hua
AU - Pan, Youmin
AU - Ballini, Jean Pierre
AU - Klepetko, Walter
AU - Decosterd, Laurent Arthur
AU - Stupp, Roger
AU - Ris, Hans Beat
N1 - Funding Information:
The Swiss National Science Foundation (No. 3200–59550) and the Fondation Andreas P. Naef pour la Chirurgie Thoracique have supported this study.
PY - 2006/12
Y1 - 2006/12
N2 - Background: Antegrade and retrograde doxorubicin-based isolated lung perfusions were compared in rodents bearing a sarcomatous tumor in the perfused lung. Inasmuch as these tumors derive their vascularization from the bronchial artery system, we hypothesized that retrograde isolated lung perfusion through the pulmonary vein might result in an improved tumor drug uptake. Methods: Single-pass antegrade (n = 9) and retrograde (n = 9) isolated left lung perfusions were performed with 100 μg of doxorubicin in Fischer rats 10 days after subpleural tumor cell injection. The perfusion, washout, and recirculation times were 20, 10, and 60 minutes, respectively, followed by harvesting of the lung. The doxorubicin concentration and compartmental distribution in the tumor and in normal parenchyma of each perfused lung were measured by high-pressure liquid chromatography (6 animals of each group) and fluorescence microscopy (3 animals of each group). Results: Doxorubicin concentration and pattern of doxorubicin-based fluorescence signaling were comparable for both perfusion techniques in normal lung tissue. Antegrade and retrograde isolated lung perfusion resulted in similar tumor drug uptake, which was lower than in normal lung parenchyma, and in weak and sporadic fluorescence signaling emerging from the tumor periphery and from blood vessels situated within the tumor tissue. Conclusions: Retrograde isolated lung perfusion did not confer a better doxorubicin uptake in the tumor as compared with antegrade lung perfusion despite the fact that the tumor vascularization in this model is based on the bronchial artery circulation.
AB - Background: Antegrade and retrograde doxorubicin-based isolated lung perfusions were compared in rodents bearing a sarcomatous tumor in the perfused lung. Inasmuch as these tumors derive their vascularization from the bronchial artery system, we hypothesized that retrograde isolated lung perfusion through the pulmonary vein might result in an improved tumor drug uptake. Methods: Single-pass antegrade (n = 9) and retrograde (n = 9) isolated left lung perfusions were performed with 100 μg of doxorubicin in Fischer rats 10 days after subpleural tumor cell injection. The perfusion, washout, and recirculation times were 20, 10, and 60 minutes, respectively, followed by harvesting of the lung. The doxorubicin concentration and compartmental distribution in the tumor and in normal parenchyma of each perfused lung were measured by high-pressure liquid chromatography (6 animals of each group) and fluorescence microscopy (3 animals of each group). Results: Doxorubicin concentration and pattern of doxorubicin-based fluorescence signaling were comparable for both perfusion techniques in normal lung tissue. Antegrade and retrograde isolated lung perfusion resulted in similar tumor drug uptake, which was lower than in normal lung parenchyma, and in weak and sporadic fluorescence signaling emerging from the tumor periphery and from blood vessels situated within the tumor tissue. Conclusions: Retrograde isolated lung perfusion did not confer a better doxorubicin uptake in the tumor as compared with antegrade lung perfusion despite the fact that the tumor vascularization in this model is based on the bronchial artery circulation.
UR - http://www.scopus.com/inward/record.url?scp=33751161899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751161899&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2006.05.048
DO - 10.1016/j.athoracsur.2006.05.048
M3 - Article
C2 - 17126104
AN - SCOPUS:33751161899
VL - 82
SP - 2024
EP - 2030
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 6
ER -